In an adult patient with moderate-severe alopecia areata, without prior systemic JAKi therapy, which agent do you prefer as your first-line therapeutic choice?

In an adult patient with moderate-severe alopecia areata, without prior systemic JAKi therapy, which agent do you prefer as your first-line therapeutic choice?

• Baricitinib
• Ritlecitinib
• Deuruxolitinib
• Tofacitinib (Off Label)
• Upadacitinib (Off Label)
• Not enought experience
• Other